Homburger acted as Swiss counsel to AtlasEdge, a renowned pan-European Edge data centre provider, on a scalable EUR 725 m loan financing. The financing was underwritten by mandated lead arranger ING Bank, as well as ABN Amro, Crédit Agricole CIB, The Bank of Nova Scotia, National Westminster Bank, Banco Santander and UniCredit Bank. The innovative […]
Ironwood Pharmaceuticals (Nasdaq: IRWD), a healthcare company specializing in GI treatments, and VectivBio Holding (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on developing innovative therapies for severe rare gastrointestinal conditions, have reached an agreement where&
A team from Homburger, led by Daniel Haeberli (financing, pictured) and included Fabrice Eckert (financing) and Stefan Otsterhelt (Tax), has offered legal counsel to MusicBird in relation to various financing aspects. MusicBird, established in 2020, has
Walder Wyss advised a banking syndicate led by Zürcher Kantonalbank as mandated lead arranger, bookrunner, coordinator and agent on the new CHF 150 million credit facility agreement for Bauwerk Group. With a turnover of around
Banking & Finance
Corporate
Tech
Homburger: wefox revolving credit facility and a Series D extension
Wefox the Berlin-based insurtech company, has secured a EUR 50 m revolving credit facility arranged by J.P. Morgan Securities and Barclays Bank, following a USD 55 m second close in its Series D that was completed
Homburger acted as counsel to Swarovski International Holding in connection with the extension of its revolving credit facility, arranged by, amongst others, UBS Switzerland AG and Credit Suisse (Switzerland). Homburger advised Swarovski International Holding and
Homburger advised the initial purchasers and arrangers in connection with CABB group’s EUR 250 million senior secured floating rate notes and EUR 420 million 8.75% senior secured fixed rate notes due 2028 and a new EUR 110 million revolving
Walder Wyss team advised the funds managed by Pharmakon Advisors, LP, in connection with the closing of the term loan financing of Reata Pharmaceuticals for up to USD 275 million. Reata Pharmaceuticals, is a global biopharmaceutical
Homburger acted as counsel to Fluence in connection with certain financing aspects of the acquisition of Nispera. Headquartered in Arlington, USA, Fluence is a global provider of energy storage products, services and digital applications for
The CABB Group has successfully concluded its refinancing round. New bonds with a total volume of EUR 670 million and terms until 2028 were successfully placed with institutional investors. The issue comprises two tranches: EUR 420 million with
